Samsung has unveiled a processor it hopes will become the cornerstone of the next-generation of wearable devices. The chip is designed to gather and process data on body fat, skeletal muscle mass, heart rate and rhythm, skin temperature and stress, setting it up to power devices with capabilities beyond those of the current generation of wearables.
A survey of 500 health professionals in the U.K. found that 48% plan to introduce mobile health apps to their practice in the next 5 years, and 81% believe they will increase their knowledge of patients' conditions.
The acquisition tightens BBK's ties to the team that helped to develop its patient and site engagement mobile app, My Clinical Study Buddy.
There have been roughly two dozen digital health-related FDA clearances so far in 2014.
Apple's HealthKit data-sharing platform for mobile health apps has been pulled from the iPhone 6's operating system after an upgrade to iOS 8 disrupted cellular service, resulting in a bucketful of delayed app launches or upgrades, to the benefit of competitors.
The market for mHealth data aggregation platforms has become increasingly congested over the past year, with Apple and Google joining the more healthcare industry-focused Validic. Now Vivametrica has joined the space, outlining plans for a platform that fixes the inconsistencies in data from consumer mHealth products and combines them with outputs from medical devices.
Less than one year has passed since a $760,000, Mark Cuban-backed seed round put Validic on the map, but the firm and its health data aggregation platform have come a long way in the intervening months. And with Validic's scale and ambition growing, the company has raised $5 million in first round funding.
Over the past year, many tech heavyweights have begun moving into the mHealth sector. Developers got an early look at Google's offering this week, with the search giant releasing a preview version of its APIs for health app developers.
Falling sales of personal computers have chipped away at one of the cornerstones of Intel's business over the past few years. The chipmaker has responded by diversifying and this week made three such moves, each of which has implications for the life sciences sector.
With the likes of Pfizer keen for clinical trial participants to track their personal health data--and Apple and Google readying to provide the technology--mobile and wearables look set to make an impact on research. But does the public want to give researchers access to their data?